← Current compounder rows

Current NDC auxiliary source row compounder:3101

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source
ndc_compounder_zip
Product Ndc Raw
69852-496
Product Ndc
69852-496
Product Ndc Digits
69852496
Product Type Name
HUMAN COMPOUNDED DRUG
Proprietary Name
Triamcinolone Acetonide 80 mg/mL
Proprietary Name Suffix
[empty]
Nonproprietary Name
Triamcinolone Acetonide 80 mg/mL
Dosage Form Name
INJECTION, SUSPENSION
Route Name
INTRAMUSCULAR
Marketing Category Name
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name
Eagle Pharma Outsourcing, LLC
Establishment Name
Eagle Pharma Outsourcing, LLC
Establishment Fei
[empty]
Substance Name
TRIAMCINOLONE ACETONIDE
Active Ingredients Info
800 mg/10 mL
History Active Ingredients Raw
TRIAMCINOLONE ACETONIDE
History Active Ingredients Info Raw
800 mg/10 mL
History Dosage Raw
INJECTION, SUSPENSION
Dea Schedule
[empty]
Package Ndc Raw
69852-496-10
Package Ndc
69852-496-10
Package Ndc Digits
6985249610
Package Ndc11
69852049610
Package Description
10 mL in 1 VIAL, MULTI-DOSE (69852-496-10)
Reporting Period Raw
2025-2
Reporting Period
2025-2
Normalization Status
valid
Source Url
https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive
compounders_ndc_directory.zip
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Last Modified
Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256
222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256
f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id
compounder:3101
Source Row Number
3101
Source Row Hash
5259548ed9ca8f16e234ef1a0f18aabd194fe3018afaebdd4ef10f4d79acb32d
Import Run Id
20261119T172627Z
Loaded At
2026-11-19 17:42:45

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAMUSCULAR",
    "PRODUCTNDC": "69852-496",
    "DEASCHEDULE": "",
    "LABELERNAME": "Eagle Pharma Outsourcing, LLC",
    "SUBSTANCENAME": "TRIAMCINOLONE ACETONIDE",
    "DOSAGEFORMNAME": "INJECTION, SUSPENSION",
    "NDCPACKAGECODE": "69852-496-10",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Triamcinolone Acetonide 80 mg/mL",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Triamcinolone Acetonide 80 mg/mL",
    "PACKAGEDESCRIPTION": "10 mL in 1 VIAL, MULTI-DOSE (69852-496-10) ",
    "ACTIVEINGREDIENTSINFO": "800 mg/10 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset
compounder
Record Source
ndc_compounder_zip
Source Record Id
compounder:3101
Source Row Number
3101
Status Scope
package
Lookup Ndc
69852-496-10
Lookup Ndc Digits
6985249610
Product Ndc
69852-496
Product Ndc Digits
69852496
Package Ndc
69852-496-10
Package Ndc Digits
6985249610
Package Ndc11
69852049610
Product Id
[empty]
Status Code
COMPOUNDER
Status Label
Outsourcing facility compounded drug report
Reporting Period Raw
2025-2
Reporting Period
2025-2
Source Table
fda_ndc_aux_compounder
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Row Hash
5259548ed9ca8f16e234ef1a0f18aabd194fe3018afaebdd4ef10f4d79acb32d
Import Run Id
20261119T172627Z
Loaded At
2026-11-19 17:42:45